Overview Fundamentals API Earnings EOD API Sample Code Pricing

Fulgent Genetics Inc (FLGT NASDAQ) stock market data APIs

$20.97 0.02(0.1%) as of July 12, 2024
Price chart is built with Anychart

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.

Fulgent Genetics Inc Financial Data Overview

627 M
29 924 K
288 M
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'FLGT',
Type: 'Common Stock',
Name: 'Fulgent Genetics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00DR7LTG2',
CIK: '1674930',
EmployerIdNumber: '81-2621304',
FiscalYearEnd: 'December',
IPODate: '2016-09-29',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
HomeCategory: 'Domestic',
IsDelisted: false,

Fulgent Genetics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 288 M
  • EBITDA -43 742 000
  • Earnings Per Share -5.56
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Fulgent Genetics Inc Earnings via APIs

  • Latest Release 2024-05-03
  • EPS/Forecast -0.32

Get Fulgent Genetics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?